This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Consiglio Nazionale Delle Richerche, Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione-Istituto Dermopatico Dell'immacolata, Università Degli Studi Di Roma "La Sapienza". Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 31 
1 out of 2 
1 out of 63 
Years Active: 2012
Title: Cristina Maria Failla: Inventor in Proangiogenic Peptide Research.
Introduction
Cristina Maria Failla is an inventor associated with Rome, Italy. Her patent work concerns a peptide derived from vascular endothelial growth factor receptor 1 (VEGFR-1) that binds integrin α5β1 and has proangiogenic activity.
Latest Patents
The available information lists one patent for Failla: “Peptide Derived from Vascular Endothelial Growth Factor Receptor-1 Binding Integrin α5β1 Having Proangiogenic Activity.” The patent describes a peptide sequence isolated from domain II of the immunoglobulin-like region of VEGFR-1. The peptide may be used in preparing pharmacological agents with proangiogenic activity. Failla is credited with 1 patent.
Career Highlights
Failla is associated with the Provincia Italiana della Congregazione dei Figli dell’Immacolata Concezione – Istituto Dermopatico dell’Immacolata and the Consiglio Nazionale delle Ricerche. The available details connect her work with research into peptide-based approaches to promoting angiogenesis.
Collaborations
Her listed coworkers include Angela Orecchia and Anna Tramontano.
Conclusion
Cristina Maria Failla’s recorded patent highlights research into a VEGFR-1-derived peptide with potential applications in proangiogenic pharmacological agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile